MN-VÄRDE-PARTNERS
Värde Partners, a leading global alternative investment firm, is pleased to announce that Brendan Albee has been promoted to Partner.
“Over the past six years, Brendan has demonstrated strong leadership and character while driving advances in scaling our world-class global operations and infrastructure. His direction and forethought have proven instrumental to the growth and success of the firm in many ways, not least of which includes ensuring Värde was well prepared with the technology and systems for a seamless transition to remote work in 2020. We are excited to welcome him as a partner,” said George Hicks, Värde Co-Founder and Co-CEO, and Ilfryn Carstairs, Co-CEO and CIO.
Brendan joined Värde in 2014 to serve as the firm’s Chief Operating Officer with global responsibility for the accounting, treasury, valuations, operations and technology functions. Based in Minneapolis, he is a member of the firm’s Investment Committee, Senior Leadership Committee, and Operating Committee. He is also active in the firm’s fund and product development as well as enterprise risk management.
Prior to joining Värde, Brendan served as global COO for the Alternative Asset Management, Equities, Structured Products, Asset Servicing and Securities Operations teams at Barclays Bank. Prior to Barclays, Brendan spent more than a decade in various roles within audit, investment banking, and strategy at JPMorgan Chase.
Alongside Brendan’s appointment, Värde announced two promotions to Senior Managing Director:
- Ria Nova, Head of Americas Business Development and Investor Relations, also oversees the firm’s consultant, intermediary and product specialist efforts. Based in New York, she joined the firm in 2017.
- Michael Reimler, Global Head of Finance, is responsible for leading and managing the accounting and financial reporting for Vӓrde’s investment funds, general partner entities and management companies, and for leading and managing the firm’s Treasury function. Based in Minneapolis, he joined the firm in 2010.
In addition, Värde recently hired Monty Cook as Head of Financial Services, North America. Based in New York, Monty leads the firm’s investing in financial services assets across North America with a focus on private credit investments in traditional and emerging asset classes. He reports to Aneek Mamik, Global Co-Head of Financial Services.
“We’re pleased to welcome Monty at an exciting time for the financial services team,” said Aneek. “Leveraging Monty’s tremendous industry experience and the strength of Värde’s platform, we are pleased to be expanding our lending solutions for the financial services sector and building on the firm’s capabilities to deliver value for investors.”
Monty joins Värde from First Eagle Alternative Credit, where he served as Head of Financial Services. Monty was with THL Credit for seven years before it was acquired by First Eagle and most recently served as Co-Head of Direct Lending. Prior to THL Credit, Monty was a Director in Deutsche Bank’s Credit Solutions Group where he sourced and structured credit investments across numerous specialty finance and other asset classes.
About Värde Partners:
Värde Partners is a leading global alternative investment firm with roots in credit and distressed. Founded in 1993, the firm has invested more than $75 billion since inception and manages over $14 billion on behalf of a global investor base. The firm’s investments span corporate and traded credit, real estate and mortgages, private equity and direct lending. Värde employs more than 300 professionals worldwide with offices in Minneapolis, New York, London, Singapore and other cities in Asia and Europe. For more information, please visit www.varde.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005214/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 01:00:00 CET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 19:32:00 CET | Press release
First Marketing Authorization granted in France for the treatment of ricin poisoning, one of the most toxic natural substances in the world and a recognized priority biological threat. Ricimed® addresses a previously unmet medical need in the management of severe and potentially fatal ricin intoxications.Supported by the French Ministry of the Armed Forces and Veterans Affairs (the Directorate General of Armaments and the French Military Health Service), the development of Ricimed® illustrates Fabentech’s transition to a new scale and, with recent support from the European HERA Invest program, reinforces its positioning as a reference player in medical countermeasures against biological threats, serving both civilian and military markets. Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release featur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
